These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18182989)

  • 41. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways.
    Tsao TS; Tomas E; Murrey HE; Hug C; Lee DH; Ruderman NB; Heuser JE; Lodish HF
    J Biol Chem; 2003 Dec; 278(50):50810-7. PubMed ID: 14522956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.
    Pajvani UB; Du X; Combs TP; Berg AH; Rajala MW; Schulthess T; Engel J; Brownlee M; Scherer PE
    J Biol Chem; 2003 Mar; 278(11):9073-85. PubMed ID: 12496257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).
    Tsao TS; Murrey HE; Hug C; Lee DH; Lodish HF
    J Biol Chem; 2002 Aug; 277(33):29359-62. PubMed ID: 12087086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.
    Otvos L; Kovalszky I; Olah J; Coroniti R; Knappe D; Nollmann FI; Hoffmann R; Wade JD; Lovas S; Surmacz E
    Biopolymers; 2015 May; 104(3):156-66. PubMed ID: 25683126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adiponectin inhibits murine pancreatic cancer growth.
    Kato M; Watabe K; Tsujii M; Funahashi T; Shimomura I; Takehara T
    Dig Dis Sci; 2014 Jun; 59(6):1192-6. PubMed ID: 24801685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antiandrogen flutamide inhibits growth of mcf-7 human breast-cancer cell-line.
    Dimonaco M; Brignardello E; Leonardi L; Gatto V; Gallo M; Pizzini A; Boccuzzi G
    Int J Oncol; 1993 Apr; 2(4):653-6. PubMed ID: 21573607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity.
    Hossain MI; Thomas AG; Mahdi F; Adam AT; Akins NS; Woodard MM; Paris JJ; Slusher BS; Le HV
    RSC Adv; 2021 Feb; 11(13):7115-7128. PubMed ID: 33777357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin: a relevant player in obesity-related colorectal cancer?
    La Cava A
    Gut; 2013 Apr; 62(4):483-4. PubMed ID: 22851665
    [No Abstract]   [Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
    Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
    Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversion of breast epithelial polarity alterations caused by obesity.
    Holmes J; Gaber M; Jenks MZ; Wilson A; Loy T; Lepetit C; Vitolins MZ; Herbert BS; Cook KL; Vidi PA
    NPJ Breast Cancer; 2023 May; 9(1):35. PubMed ID: 37160903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Adiponectin in Breast Cancer.
    Nehme R; Diab-Assaf M; Decombat C; Delort L; Caldefie-Chezet F
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The EASO New Investigator Award in Clinical Research 2021: Role of Chronotype in Obesity.
    Muscogiuri G
    Obes Facts; 2023; 16(2):131-140. PubMed ID: 36349806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pleiotropic roles of adipocyte secretome in remodeling breast cancer.
    Zhou X; Zhang J; Lv W; Zhao C; Xia Y; Wu Y; Zhang Q
    J Exp Clin Cancer Res; 2022 Jun; 41(1):203. PubMed ID: 35701840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.
    Manley SJ; Olou AA; Jack JL; Ruckert MT; Walsh RM; Eades AE; Bye BA; Ambrose J; Messaggio F; Anant S; VanSaun MN
    Cell Death Dis; 2022 Feb; 13(2):114. PubMed ID: 35121743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between diabetes, obesity, aging, and cancer: review of recent literature.
    Qiang JK; Lipscombe LL; Lega IC
    Transl Cancer Res; 2020 Sep; 9(9):5743-5759. PubMed ID: 35117936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D deficiency: a potential risk factor for cancer in obesity?
    Migliaccio S; Di Nisio A; Magno S; Romano F; Barrea L; Colao AM; Muscogiuri G; Savastano S
    Int J Obes (Lond); 2022 Apr; 46(4):707-717. PubMed ID: 35027681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin Resistance and Cancer: In Search for a Causal Link.
    Chiefari E; Mirabelli M; La Vignera S; Tanyolaç S; Foti DP; Aversa A; Brunetti A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions Between Adiponectin-Pathway Polymorphisms and Obesity on Postmenopausal Breast Cancer Risk Among African American Women: The WHI SHARe Study.
    Nam GE; Zhang ZF; Rao J; Zhou H; Jung SY
    Front Oncol; 2021; 11():698198. PubMed ID: 34367982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells.
    Rangel N; Villegas VE; Rondón-Lagos M
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting obesity-related dysfunction in hormonally driven cancers.
    Rubinstein MM; Brown KA; Iyengar NM
    Br J Cancer; 2021 Aug; 125(4):495-509. PubMed ID: 33911195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.